文献速递小儿神经外科与脑积水神经重症

多学科方法改进脑室造瘘管理:降低风险与成本

Improving Ventriculostomy Management: Risk and Cost Reduction Through a Multidisciplinary Approach.
PubMed 文献 · World Neurosurg · 2018-11-14

该质量改进项目回顾性分析了2008年6月至2016年12月行脑室造瘘的患者,分三阶段依次实施抗生素涂层导管和减少脑脊液采样频率。

要点

  • 使用抗生素涂层导管并减少脑脊液采样频率可显著降低脑室造瘘相关感染率。
  • 感染率从阶段1的3.3例/1000装置日降至阶段2的1.6和阶段3的0.8(P=0.01)。

核心结论

  • 使用抗生素涂层导管联合减少脑脊液采样频率可节省成本并显著降低装置相关感染。

研究设计与样本

  • 回顾性研究,纳入2008年6月至2016年12月行脑室造瘘的患者,分三阶段:阶段1(2008年6月至2010年8月)使用非抗生素涂层导管并每日脑脊液采样;阶段2(2010年9月至2013年1月)使用抗生素涂层导管;阶段3(2013年2月至2016年12月)脑脊液采样频率降至每周两次。

主要发现

  • 阶段1平均感染率为3.3例/1000装置日,阶段2为1.6,阶段3为0.8。
  • 使用抗生素涂层导管和减少脑脊液采样使脑室造瘘相关感染率下降75.8%(P=0.01)。
  • 2014年期间无脑室造瘘相关感染发生。
  • 该干预平均每患者每日预计节省175美元,成本降低72%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Infection is a life-threatening complication of ventriculostomy. The purpose of this quality improvement project was to develop a cost-effective, evidence-based intervention to reduce ventriculostomy-associated infection (VAI) rates. METHODS: In this retrospective study, patients undergoing ventriculostomy insertion between June 2008 and December 2016 were identified, and charts were reviewed. The study period between June 2008 and August 2010 constituted the baseline (phase 1) in which non-antibiotic-coated ventriculostomy catheters were used and cerebrospinal fluid (CSF) sampling was done daily. Then, 2 sequential interventions were implemented. Between September 2010 and January 2013, antibiotic-coated ventriculostomy catheters (AC-Vs) were used (phase 2). Then, between February 2013 and December 2016, the frequency of CSF sampling was minimized to twice a week (phase 3). The rates of VAI and operational costs, or cost incurred for the external ventricular drain catheter, antibiotics, laboratory analysis, and CSF sampling supplies, were compared for each phase. RESULTS: The average infection rate for phase 1 was 3.3 infections per 1000 device-days. The VAI rates for phases 2 and 3 were 1.6 and 0.8, respectively. The use of AC-Vs and reduced CSF sampling resulted in a VAI rate decrease of 75.8% (P = 0.01). During 2014, there were no VAIs. The intervention produced an estimated $1.02 million in savings for the institution during phase 3. The average projected savings of this intervention was $175 per patient per day and reduced cost by 72%. CONCLUSIONS: The use of AC-Vs in combination with decreased frequency of CSF sampling was cost saving and resulted in a significant reduction in device-related infections.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Angulo M, Springer L, Behbahani M, et al. Improving Ventriculostomy Management: Risk and Cost Reduction Through a Multidisciplinary Approach. World Neurosurg. 2018. PMID: 30447459. doi:10.1016/j.wneu.2018.11.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。